Gonioscopy is a painless exam your ophthalmologist uses to check a part of your eye called the drainage angle. This area is at the front of your eye between the iris and the cornea. It is where fluid called aqueous humor naturally drains out of your eye.
Gonioscopy is using a gonio-lens (also known as a gonioscope) together with a slit lamp or operating microscope to view the iridocorneal angle, or the anatomical angle formed between the eye's cornea and iris.
It’s main goal is to thoroughly evaluate eye health and properly diagnose eye diseases such as glaucoma, which is the second leading cause of blindness.

Why Gonioscopy?
Gonioscopy is usually suggested along with other tests to confirm and evaluate gravity of eye problems. Other tests may include tonometry (to measure eye pressure), slit lamp examination, perimetry (to determine range of vision), and ophthalmoscopy (to check the optic nerves).

When Should You Have a Gonioscopy?
Early signs of vision changes and eye disease may begin around age 40. This is when all adults should get a baseline eye disease screening with an ophthalmologist.

Possible Risks and Complications
 There is usually no pain felt in a gonioscopy exam, and the test only lasts a few minutes. While the test itself does not usually cause discomfort, the initial application of the anaesthetic eyedrops may cause a slight burning sensation.
 When the pupils become dilated due to the exam, the patient may experience blurred vision in the next several hours after the test. It is important for the eyes not to be rubbed for the next 30 minutes after the test is done, or until the eye drop medicine wears off. Contact lenses must not be worn during this time as well.
 Among minor risks associated with this test include allergic reaction to the anaesthetic eyedrops and/or eye infection.

The journal invites different types of articles including original research article, review articles, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication.
A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing. Manuscripts can be uploaded directly through mail id: ophthalmologist@eclinicalsci.com or forwarded to the Editorial Office at https://www.pulsus.com/ophthalmologist-clinical-therapeutic-journal.html

How we work:
• After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
• A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
• Author proof is generated within 7 working days after the acceptance decision.

Benefits on Publication:
Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.
Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.
Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.
Colour Art: In a world of black & white journal articles, high-quality full-colour images make your article stand out from the crowd and tell a complete story, increasing readers and citations.
Social Media Exposure: Extended reach for your article through links on Twitter accounts provides maximum visibility worldwide.
Reprints: Distribute your work to colleagues and at conferences as we provide hard copy colour reprints of your article on order.

Media Contact:
Sarah Rose
Journal Manager
The Ophthalmologist: Clinical and Therapeutic Journal
Email: ophthalmologist@eclinicalsci.com